Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,400 people across 40 countries.
[Upcoming Webinar] Revolutionizing Obesity Clinical Trials: A Patient-Centric Approach July 22, 2024 3:35pm
In an upcoming webinar, Sr. Director of Clinical Trial Management Jennifer Brown and Advanced Clinical Practitioners Amanda Sylvester, DNP, APRN,...
The post [Upcoming Webinar] Revolutionizing Obesity Clinical Trials: A Patient-Centric Approach appeared first on Medpace Corporate.
View this post
Medpace Continues to Lead: Recognized with 2024 CRO Leadership Awards June 28, 2024 1:15pm
Medpace, a global, full-service clinical research organization (CRO), reaffirms its industry leadership by once again being recognized with CRO Leadership Awards presented by Life Science Leader and Clinical Leader. Medpace received five awards across all categories, including Capabilities, Compatibility, Expertise, Quality, and Reliability.
The post Medpace Continues to Lead: Recognized with 2024 CRO Leadership Awards appeared first on Medpace Corporate.
View this post
Key Learnings from European Congress on Obesity and ENDO June 24, 2024 11:07am
Discover key learning from the European Congress on Obesity and ENDO 2024 conferences.
The post Key Learnings from European Congress on Obesity and ENDO appeared first on Medpace Corporate.
View this post
Oncology Breakthroughs – ASCO 2024 Highlights June 13, 2024 2:53pm
Explore insights from Medpace oncology experts as they identify several of the latest innovations in hematologic and oncologic research shared at ASCO 2024.
The post Oncology Breakthroughs – ASCO 2024 Highlights appeared first on Medpace Corporate.
View this post
Innovations in Infectious Diseases & Vaccines Clinical Development – Highlights from ESCMID Global 2024 May 29, 2024 3:05pm
Medpace infectious diseases and vaccines experts share key takeaways from ESCMID Global 2024 in Barcelona, Spain.
The post Innovations in Infectious Diseases & Vaccines Clinical Development – Highlights from ESCMID Global 2024 appeared first on Medpace Corporate.
View this post
Medpace Expands Medical Leadership Team in Asia Pacific May 16, 2024 11:15am
Medpace is pleased to announce the addition of four experienced medical experts, Dr. Shinichi Asabe, Dr. Morihiro Watanabe, Dr. Kiyoshi...
The post Medpace Expands Medical Leadership Team in Asia Pacific appeared first on Medpace Corporate.
View this post
Like